Mostrando 2 resultados de: 2
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
ArticleAbstract: Extension of the interval between vaccine doses for the BNT162b2 mRNA vaccine was introduced in thePalabras claves:antibody, B cell, BNT162b2, covid-19, dosing interval, Neutralization, SARS-COV-2, T cell, Vaccine, variants of concernAutores:Abuelgasim H., Adele S., Adland E., Adlou S., Akther H.D., Al-Taei S., Alhussni A., Ali M., Altmann T., Amini A., Angyal A., Arancibia-Cárcamo C.V., Austin J.A., Azim Ansari M., Barnes E., Bayley M., Bridges-Webb A., Brown A., Brown H., Brown R., Carroll M.W., Chalk J., Chand M., Chawla A., Chinnakannan S., Conlon C.P., Cross A., Cutteridge J., de Lara C., de Silva T.I., Deeks A.S., Dejnirattisai W., Denly L., Diffey B., Dimitriadis S., Dobson S.L., Dold C., Donnison T., Drake T.M., Dunachie S.J., Duncan C.J.A., Dupont M., Eyre D.W., Fairman A., Faustini S., Foulkes S., Frater J., Gardiner S., Gillson N., Goulder P., Hackstein C.P., Hall V., Hambleton S., Haniffa M., Hargreaves A., Haworth J., Hering L.M., Holmes J., Hopkins S., Horner E., Hornsby H., Jämsén A., Javier Gilbert Jaramillo, Jeffery K., Johnson S.A., Jones C., Kasanyinga M., Kelly S., Kilby J.A., Kirk R., Klenerman P., Knight M.L., Lawrie A., Lee L., Linder A., Longet S., Malone T., Matthews P.C., Meardon N., Mongkolsapaya J., Moore S.C., Nicols A.R., Payne R.P., Phillips E., Pollard A.J., Reyes L.S., Richter A., Rowland-Jones S.L., Saei A., Sandhar G., Screaton G.R., Shields A., Skelly D.T., Stafford L., Supasa P., Tipton T., Turtle L., Tyerman J.K., Whitham R., Wootton D.G.Fuentes:scopusT-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study
ArticleAbstract: Background: Previous infection with SARS-CoV-2 affects the immune response to the first dose of thePalabras claves:Autores:Abuelgasim H., Adland E., Adlou S., Alhussni A., Ali M., Angyal A., Austin J.A., Azim Ansari M., Barnes E., Bayley M., Brown A., Brown H., Brown R., Carroll M.W., Chand M., Chawla A., Conlon C.P., Cross A., Cutteridge J., de Silva T.I., Deeks A.S., Denly L., Diffey B., Dobson S.L., Dold C., Dunachie S.J., Duncan C.J.A., Fairman A., Frater J., Gardiner S., Gillson N., Goulder P., Hall V., Harding A.C., Harrington K., Haworth J., Hering L.M., Holmes J., Hopkins S., Hornsby H., James W.S., Jämsén A., Javier Gilbert Jaramillo, Jeffery K., Jones C., Kasanyinga M., Kilby J.A., Kirk R., Klenerman P., Lawrie A., Lett L., Lillie K., Longet S., Marsh L., Matthews P., Matthews P.C., Meardon N., Mehta H., Moore S.C., Nicols A.R., O'Donnell D., Ogbe A., Pace M., Payne R.P., Platt G., Richter A., Romaniuk L., Rongkard P., Rowland-Jones S.L., Sandhar G., Shields A., Skelly D.T., Smith N., Spegarova J.S., Subramaniam K., Thomas S.R., Tipton T., Tucker S., Turtle L., Turton H., Tyerman J.K., Watson A.J.R., Watson L., Webb-Bridges A., Weeks E., Whitham R., Wilson R., Wood S., Xiao H., Zawia A.Fuentes:scopus